IPAD-DB ID | C00818 |
Name | Ellagic acid |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 4 H 6 O 8 |
Molecular Weight | 302.19g/mol |
IUPAC Name | 6, 7, 13, 14-tetrahydroxy-2, 9-dioxatetracyclo[6.6.2.04, 16.011, 15]hexadeca-1(15), 4, 6, 8(16), 11, 13-hexaene-3, 10-dione |
InChI | InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7)9(5)17)2-6(16)10(18)12(8)21-13(3)19/h1-2, 15-18H |
InChIKey | AFSDNFLWKVMVRB-UHFFFAOYSA-N |
Canonical SMILES | C1=C2C3=C(C(=C1O)O)OC(=O)C4=CC(=C(C(=C43)OC2=O)O)O |
PubChem CID | 5281855 |
DrugBank Accession Number | - |
CAS Registry Number | 476-66-4 |
Molecular Weight(Computed by SwissADME) | 302.19 |
Hac(Computed by SwissADME) | 22 |
Volume(Computed by ADMETlab 2.0) | 265.705 |
Density(Computed by ADMETlab 2.0) | 1.137 |
nRing(Computed by ADMETlab 2.0) | 4 |
MaxRing(Computed by ADMETlab 2.0) | 14 |
nHet(Computed by ADMETlab 2.0) | 8 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 21 |
Flexibility(Computed by ADMETlab 2.0) | 0 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -4.666 |
LogD(Computed by ADMETlab 2.0) | 0.794 |
logP(Computed by ADMETlab 2.0) | 1.31 |
TPSA(Computed by SwissADME) | 141.34 Ų |
Hbond Acceptor(Computed by SwissADME) | 8 |
Hbond Donor(Computed by SwissADME) | 4 |
Rotatable Bonds(Computed by SwissADME) | 0 |
GI Absorption(Computed by SwissADME) | |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | |
P-gp Substrate(Computed by SwissADME) | |
CYP1A2 Inhibitor(Computed by SwissADME) | |
CYP2C19 Inhibitor(Computed by SwissADME) | |
CYP2C9 Inhibitor(Computed by SwissADME) | |
CYP2D6 Inhibitor(Computed by SwissADME) | |
CYP3A4 Inhibitor(Computed by SwissADME) | |
log Kp(Skin Permeation)(Computed by SwissADME) |
Lipinski(Computed by SwissADME) | |
Ghose(Computed by SwissADME) | |
Veber(Computed by SwissADME) | |
Egan(Computed by SwissADME) | |
Muegge(Computed by SwissADME) | |
Bioavailability Score(Computed by SwissADME) |